Earnings Report: Anupam Rasayan India Ltd Missed Revenue Estimates By 9.2%
The second-quarter results for Anupam Rasayan India Ltd (NSE:ANURAS) were released last week, making it a good time to revisit its performance. Revenues came in 9.2% below expectations, at ₹2.9b. Statutory earnings per share were relatively better off, with a per-share profit of ₹11.87 being roughly in line with analyst estimates. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Anupam Rasayan India after the latest results.
See our latest analysis for Anupam Rasayan India
After the latest results, the seven analysts covering Anupam Rasayan India are now predicting revenues of ₹16.2b in 2025. If met, this would reflect a major 31% improvement in revenue compared to the last 12 months. Per-share earnings are expected to leap 269% to ₹23.50. In the lead-up to this report, the analysts had been modelling revenues of ₹16.3b and earnings per share (EPS) of ₹15.03 in 2025. Although the revenue estimates have not really changed, we can see there's been a considerable lift to earnings per share expectations, suggesting that the analysts have become more bullish after the latest result.
The consensus price target was unchanged at ₹734, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Anupam Rasayan India analyst has a price target of ₹1,075 per share, while the most pessimistic values it at ₹520. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. The analysts are definitely expecting Anupam Rasayan India's growth to accelerate, with the forecast 71% annualised growth to the end of 2025 ranking favourably alongside historical growth of 12% per annum over the past three years. Compare this with other companies in the same industry, which are forecast to grow their revenue 13% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Anupam Rasayan India to grow faster than the wider industry.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Anupam Rasayan India following these results. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Anupam Rasayan India analysts - going out to 2027, and you can see them free on our platform here.
You should always think about risks though. Case in point, we've spotted 4 warning signs for Anupam Rasayan India you should be aware of, and 2 of them are a bit unpleasant.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:ANURAS
Anupam Rasayan India
Engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally.
High growth potential slight.